Tata Elxsi Launches Global ODC for Terumo to Accelerate Cardiac & Vascular Technologies

The newly launched centre, by integrating AI and generative AI into software and product engineering workflows, aims to accelerate development timelines, improve precision in design, and support efficient regional customization.

Tata Elxsi has partnered with Terumo Corporation to launch a Global Offshore Development Center (ODC) aimed at advancing cardiac and vascular technologies through integrated engineering, AI-driven development, and lifecycle support across international markets.

Terumo Corporation, headquartered in Japan, is widely recognized for its contributions to cardiovascular systems, blood management, and medical devices. With increasing global demand for high-performance, patient-centric cardiovascular solutions, the collaboration reflects a strategic push to scale innovation while maintaining stringent safety and compliance standards.

Tata Elxsi, a global design and technology services company based in Bengaluru, brings experience in design-led engineering, positioning it as a key partner for regulated healthcare product development.

The newly launched centre brings together multidisciplinary teams spanning design, engineering, verification, regulatory compliance, and localisation. By integrating artificial intelligence and generative AI into software and product engineering workflows, the ODC aims to accelerate development timelines, improve precision in design, and support efficient regional customization.

This approach is expected to address growing market needs for cost-effective, differentiated, and patient-focused medical devices.

The collaboration is also structured to provide continuous lifecycle support, ensuring that products meet evolving regulatory requirements and clinical expectations across different geographies.

With healthcare systems increasingly prioritizing value-based care and technological integration, such development models are becoming central to global med-tech innovation strategies.

Fumihisa Hirose, Company President, Cardiac & Vascular Company Terumo Corporation, said, “This new Offshore Development Centre strengthens our ability to innovate faster and deliver high-quality medical technologies across global markets. Tata Elxsi’s integrated design, engineering, and regulatory expertise will help us accelerate our global product roadmap while maintaining the highest standards of safety and compliance.”

Sreevatsa Sahasranaman, Sr. Vice President & Head – Healthcare & Life Sciences, Tata Elxsi, said, “We are committed to combining design, engineering, and regulatory capabilities, enhanced by the latest AI- and GenAI-powered technologies, to help Terumo bring next-gen medical technologies to global and emerging markets.”

The partnership is expected to improve the reliability, performance, and accessibility of cardiac and vascular technologies worldwide, reinforcing the role of digital engineering and AI in shaping the future of medical device innovation.

Stay tuned for more such updates on Digital Health News